Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — Capital Reinvestment Ratio
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥283.54 Million) in capital expenditures (CN¥21.27 Million). See free cash flow generation of Heilongjiang ZBD Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Heilongjiang ZBD Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Heilongjiang ZBD Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see 603567 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.15x | CN¥164.31 Million | CN¥189.15 Million | ▼ -79.4% |
| 2020 | 5.60x | CN¥155.18 Million | CN¥868.65 Million | ▲ +591.7% |
| 2019 | 0.81x | CN¥220.92 Million | CN¥178.79 Million | ▼ -29.1% |
| 2018 | 1.14x | CN¥367.40 Million | CN¥419.59 Million | ▲ +97.9% |
| 2017 | 0.58x | CN¥853.19 Million | CN¥492.42 Million | ▼ -97.1% |
| 2016 | 20.14x | CN¥15.83 Million | CN¥318.74 Million | ▲ +9644.1% |
| 2014 | 0.21x | CN¥386.32 Million | CN¥79.85 Million | ▼ -78.6% |
| 2013 | 0.97x | CN¥174.68 Million | CN¥168.73 Million | ▼ -36.1% |
| 2012 | 1.51x | CN¥154.25 Million | CN¥233.09 Million | ▲ +13.2% |
| 2011 | 1.33x | CN¥104.71 Million | CN¥139.77 Million | — |